Russian Scientists Develop Oral Drug for Diabetes and Obesity
- Published:
- First detected:
Insights by Echo AI
Scientists at Volgograd State Medical University have created 'Diapiaron', a capsule-based drug for treating type 2 diabetes and obesity. Unlike injectable drugs like Ozempic, Diapiaron acts on specific intestinal receptors (GPR119) to stimulate the body's natural hormone production for blood sugar control. The drug has shown promising results in animal studies and has completed its first phase of human trials. It is expected to be available for purchase by 2028.
Source coverage
7
records merged
0
0 unique
3
3 unique
4
4 unique
7 Sources
В России создали безопасный аналог «Оземпика» в капсулах. Ученые Вол...
Ученые из Волгограда разработали новый препарат от диабета и ожирения...
В Волгограде разработали инновационный препарат для лечения ожирения и...
💊 Российские учёные разработали инновационный препарат для лечения ожи...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
